Company Dermapharm Holding SE

Equities

DMP

DE000A2GS5D8

Pharmaceuticals

Market Closed - Xetra 11:35:13 2024-06-07 am EDT After market 12:44:50 pm
36.95 EUR -3.52% Intraday chart for Dermapharm Holding SE 37.15 +0.54%

Business Summary

Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.

Number of employees: 3,497

Sales per Business

EUR in Million2022Weight2023Weight Delta
Branded Medicine
46.9 %
- - 533 46.9 % -
Other Health Products
32.7 %
- - 372 32.7 % -
Parallel Import
20.3 %
253 24.7 % 231 20.3 % -8.92%

Sales per region

EUR in Million2022Weight2023Weight Delta
Germany
62.3 %
1,025 100.0 % 707 62.3 % -31.01%
France
13.4 %
-- 152 13.4 % -
Spain
10.4 %
-- 118 10.4 % -
Other
7.9 %
-- 90 7.9 % -
Austria / Switzerland
6.0 %
-- 69 6.0 % -

Managers

Managers TitleAgeSince
Chief Executive Officer 62 17-07-31
Director of Finance/CFO - 22-10-31
Investor Relations Contact - 18-11-30
Sales & Marketing 49 22-08-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 75 17-12-31
Chairman 68 17-07-31
Director/Board Member 63 17-07-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 53,840,000 17,368,784 ( 32.26 %) 0 32.26 %

Shareholders

NameEquities%Valuation
36,471,000 67.74 % 1 224 M €
Mawer Investment Management Ltd.
3.004 %
1,617,100 3.004 % 54 M €
Amundi Asset Management SA (Investment Management)
0.6326 %
340,571 0.6326 % 11 M €
Danske Bank A/S (Investment Management)
0.5405 %
290,995 0.5405 % 10 M €
Lupus alpha Asset Management AG
0.4842 %
260,700 0.4842 % 9 M €
Inocap Gestion SAS
0.3729 %
200,776 0.3729 % 7 M €
DNCA Finance SA
0.3543 %
190,781 0.3543 % 6 M €
Oddo BHF Asset Management SAS
0.2951 %
158,877 0.2951 % 5 M €
Joh. Berenberg, Gossler & Co. KG (Investment Management)
0.2258 %
121,571 0.2258 % 4 M €
GLS Investment Management GmbH
0.1579 %
85,000 0.1579 % 3 M €

Company contact information

Dermapharm Holding SE

Lil-Dagover-Ring 7

82031, Grunwald

+49 89 6 41 86 0

http://www.dermapharm.de
address Dermapharm Holding SE(DMP)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Pharmaceuticals: Other
Pharmaceuticals: Major
Dermapharm AG (Switzerland)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
38.3 EUR
Average target price
54.1 EUR
Spread / Average Target
+41.25%
Consensus
  1. Stock Market
  2. Equities
  3. DMP Stock
  4. Company Dermapharm Holding SE